The cost of schizophrenia: An inextricable labyrinth or a useful tool for decision makers ?;Le cout de la maladie : Un labyrinthe inextricable ou une aide a la decision ? Le cas de la schizophrenie

Encephale

Volumn 24, Issue 2, 1998, Pages 83-99

  Launois, R ^a   Toumi, M ^b   Reboul Marty, J ^a   Lancon C ^c  

^a UNIVERSITÉ PARIS 13   (France)

^b Lundbeck   (France)

^c HÔPITAL SAINTE MARGUERITE   (France)

Author keywords

Care structures (equivalencies); Cost of illness; Costing methodology

Indexed keywords

ARTICLE; AUSTRALIA; COMMUNITY CARE; FRANCE; HEALTH CARE COST; HOSPITALIZATION; INSTITUTIONALIZATION; MENTAL HEALTH SERVICE; REIMBURSEMENT; SCHIZOPHRENIA; SOCIAL SECURITY; UNITED KINGDOM; UNITED STATES; COMPARATIVE STUDY; COST CONTROL; COST OF ILLNESS; CULTURAL FACTOR; ECONOMICS; FORECASTING; HUMAN; REVIEW;

COST CONTROL; COST OF ILLNESS; CROSS-CULTURAL COMPARISON; DIRECT SERVICE COSTS; FORECASTING; FRANCE; HUMANS; SCHIZOPHRENIA;

EID: 0031750193     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. ANDREWS G, HALL W, GOLDSTEIN G et al. The economic costs of schizophrenia. Implications for public policy. Arch Gen Psychiatry 1985 ; 42 : 537-43.
2. BUDSON RD, MEEHAN J. Developing a community residence for the mentally ill. Publication 6914. Boston : Mass, Department of Mental Health, Communwealth of Massachusetts, 1974.
3. CAPRI S. Methods for evaluation of the direct and indirect costs of long term schizophrenia. Acta Psychiatr Scand 1994 ; 89 (Suppl. 382) : 80-3.
4. CONLEY R, CONWELL M, WILLNER S. The cost of mental illness. Statistical Note 30. Rockville : Md, Biometry Branch, NIMH, 1968.
5. CROW TJ, MCMILLAN JF, JOHNSON AL et al. The Northwick Park study of first episodes of schizophrenia : II. A randomised controlled trial of prophylactic neuroleptic treatment. Bri J Psychiatry 1986 ; 148 : 120-7.
6. DEPARTMENT OF HEALTH AND SOCIAL SECURITY. In-Patient Statistics from the Mental Health Inquiry for England, 1981. London : HMSO, 1984.
7. DRUMMOND MF, DAVIES LM. Economics and schizophrenia : The real cost. Bn J Psychiatry 1994 ; 165 (Suppl. 25) : 18-21.
8. FAVROD J, HUGUELET P, CHAMBON O. L'éducation au traitement neuroleptique peut-elle réduire les coûts ? Une évaluation pilote. Encephale 1996 ; XXII : 331-6.
9. FRANKENBURG FR, HEGARTY JD. Cost considerations in the treatment of schizophrenia. CNS Drugs 1996 ; 5 : 75-82.
10. FREEMAN HL, ALPERT M. Prevalance of schizophrenia in an urban population. Br J Psychiatry 1986 ; 149 : 603-11.
11. GOLDBERG D, JONES RJ. The costs and benefits of psychiatric care. In : Robin LN, Clayton PJ, Wing JK, eds. Social consequences of psychiatric illness. New York : Brunner Mazel, 1980.
12. GOLDBERG D. Cost effectiveness in the treatment of patients with schizophrenia. Acta Psychiatr Scand 1994 ; 89 (Suppl. 382) : 89-92.
13. GUNDERSON JG, MOSHER LR. The cost of schizophrenia. Am J Psychiatry 1975 ; 132 (9) : 901-6.
14. HARTUNIAN NS, SMART CN, THOMPSON MS. The incidence and economic costs of major impairments : a comparative analysis of cancer, motor vehicle injuries, heart disease and stroke. Lexington : Mass, Lexington Books, 1980.
15. JOHNSTONE EC, CROW TJ, JOHNSON AL et al. The Northwick Park study of first episodes of schizophrenia : I. Presentation of the illness and problems relating to admission. Bri J Psychiatry 1986 ; 148: 115-20.
16. KAVANAGH S, OPIT L, KNAPP M et al. Schizophrenia : shifting the balance of care. Soc Psychiatry Psychiatr Epidemiol 1995 ; 30 : 206-12.
17. MARTIN P. Impacts médico-économiques de la schizophrénie. Encephale 1995 ; Suppl. III : 67-73.
18. MOSCARELLI M. Health and economic evaluation in schizophrenia : implication for health policies. Acta Psychiatr Scand 1994 ; 89 (Suppl. 382) : 84-8.
19. PRUDO R, BLUM HM. Five-year outcome and prognosis in schizophrenia. Bri J Psychiatry 1987 ; 150 : 345-54.
20. RICE DP, KELMAN S, MILLER LS et al. The economic costs of alcohol and drug abuse and mental illness : 1985. Washington DC : Department of health and human services, 1990.
21. ROUILLON F, DANSETTE GY, LE FLOCH C. Etude de la prise en charge thérapeutique des schizophrènes et de son coût. Encephale 1994; XX: 303-9.
22. ROUILLON F, TOUMI M, DANSETTE GY et al. Some aspects of the cost of schizophrenia in France. Pharmacoeconomics 1997 ; 11 : 578-94.
23. RUPP A, KEIH SJ. The costs of schizophrenia. Assessing the burden. Psychiatric Clinics of North America 1993 ; 16 : 413-23.
24. SOUETRE E, MARTIN P, LECANU JP et al. Evaluation médico-économique des neuroleptiques dans la schizophrénie. Encephale 1992; XVIII : 263-9.
25. TERKELSEN KG, MENIKOFF A. Measuring the costs of schizophrenia. Implications for the post institutional era in the US. Pharmaeconomics 1995 ; 8 : 199-222.
26. WASYLENKI DA. The cost of schizophrenia. Can J Psychiatry 1994 ; 39 (Suppl. 2) : S65-9.
27. WEINSTEIN AS, FINNEBERG HV. Clinical decision analysis. Philadelphie : WB Saunders Company, 1980.
28. WILLIAMS R, DICKSON RA. Economics of schizophrenia. Can J Psychiatry 1995 ; 40 (Suppl. 2) : S60-7.
29. WYATT RJ, HENTER I, LEARY MC et al. An economic evaluation of schizophrenia-1991. Soc Psychiatry Psychiatr Epidemiol 1995 ; 30: 196-205.